Immune plasma therapy in COVID-19 infection: the experience of Siirt

Objective: COVID-19 pandemic which is rapidly spreading in the world affects people in Turkey significantly. Various drug-methods for treatment are being tried and one of these applications is immune plasma transfusion. Materials and Methods: In this study, 400cc immune plasma treatment was evaluated retrospectively to show the effect of treatment applied to 23 patients with COVID-19 diagnosis in Siirt Training and Research Hospital. Results: It was observed that the use of mechanical ventilation was 47.82% before the immune plasma treatment, while this need decreased to 30.43% after 3 days. Nine out of 23 patients who received immune plasma therapy recovered by completing their treatment. Conclusion: Although the immune plasma applied on patients contributes to the recovery of patients, the evidence is yet insufficient. Therefore, more COVID-19 patients need to be observed to document the efficiency of immune plasma transfusion therapy.